Hamblin et al in their recent publication examine various associations with ketosis in the colonoscopy population.1 They make the novel observation that in this high-risk population for SGLT2 inhibitor (SGLT2i)… Click to show full abstract
Hamblin et al in their recent publication examine various associations with ketosis in the colonoscopy population.1 They make the novel observation that in this high-risk population for SGLT2 inhibitor (SGLT2i) induced ketoacidosis that there is an inverse association between BMI and finger prick ketone measurement in 37 SGLT2i treated individuals and 105 individuals with type 2 diabetes (T2D) undergoing colonoscopy. This observation, albeit in a small cohort, may help identify individuals who are at high risk of ketosis and worse outcomes around colonoscopy. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.